Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Thar Pharmaceuticals Inc.
DescriptionNon-opioid, oral formulation of zoledronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsTreat complex regional pain syndrome (CRPS)
Regulatory Designation U.S. - Orphan Drug (Treat complex regional pain syndrome (CRPS))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today